PAVmed Inc. (PAVM)
About PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.
This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.
Financial summary
- Revenue FY2025
- $71.0K
- Net income
- $401.0K
- Total assets
- $38.8M
- Market cap
- $33.9M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $33.9M
- Shares outstanding
- 15.6M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Apr 28, 2016
PAVmed Inc. (PAVM) Stock Price
- Profitable — net income of $401.0K in FY2025.
- Trading 87% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review PAVmed Inc..
Write a review
News about PAVmed Inc.
News & sentiment via Polygon.io
PAVmed Inc.: frequently asked questions
Is PAVmed Inc. an American company?
PAVmed Inc. is a US-based company headquartered in New York, New York, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is PAVmed Inc. headquartered?
PAVmed Inc. is headquartered in New York, New York, United States.
Is PAVmed Inc. publicly traded?
Yes — PAVmed Inc. is a publicly traded company. Its stock trades under the ticker symbol PAVM on the NASDAQ.
What does PAVmed Inc. do?
PAVmed Inc. is an American Medical Devices company in the Health & Beauty sector.